OVERVIEW
Global transplant typing of HLA is expected to hit USD 1,267 million by 2025, increasing at a CAGR of 6.12% over the forecast period. Market growth can be attributed to factors such as the the number of solid organ, soft tissue and stem cell transplants; technical advancements in organ transplantation; increased funding, research grants and public-private investments; technical changes from serological assays to gene-based HLA profiling; and enhancement of health services through the creation of counts
TABLE OF CONTENT
1 Global HLA Typing for Transplant Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global HLA Typing for Transplant Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global HLA Typing for Transplant Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global HLA Typing for Transplant Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global HLA Typing for Transplant Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global HLA Typing for Transplant Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global HLA Typing for Transplant Market – By Technology (Market Size – & million/billion)
8.1 Non-Molecular Assay
8.2 Molecular Assay
9 Global HLA Typing for Transplant Market – By Products and Services
9.1 Instruments
9.2 Reagents and Consumables
9.3 Software and Services
10 Global HLA Typing for Transplant Market – By Application
10.1 Diagnostic Applications
10.2 Research Applications
11 Global HLA Typing for Transplant Market – By End-User
11.1 Hospitals and Transplant Centers
11.2 Research Laboratories and Academic Institutions
11.3 Commercial Service Providers
12 Global HLA Typing for Transplant Market – By Geography (Market Size – & million/billion)
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 U.K
12.3.2 Germany
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 South Korea
12.4.5 Rest of APAC
12.5 Rest of the World
12.5.1 South America
12.5.2 Middle East
12.5.3 Africa
13 Global HLA Typing for Transplant Market – Entropy
13.1 New product launches
13.2 M&A’s, collaborations, JVs and partnerships
14 Global HLA Typing for Transplant Market Company Profile (Key Players)
14.1 Market Share, Company Revenue, Products, M&A, Developments
14.2 Thermo Fisher Scientific, Inc.
14.3 F. Hoffmann-LA-Roche Limited
14.4 Immucor, Inc.
14.5 Olerup SSP AB
14.6 Qiagen N.V.
14.7 Luminex Corporation
14.8 Abbott Laboratories, Inc.
14.9 Bio-Rad Laboratories, Inc.
14.10 Illumina, Inc.
14.11 Affymetrix, Inc.
14.12 Company 11 & more
15 Global HLA Typing for Transplant Market – Appendix
15.1 Sources
15.2 Abbreviations
